AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 35393385 — intervention group
Group type: EXPERIMENTAL
Intervention: pRBC+TXA
Number of subjects: 763
Study 35393385 — intervention group
Group type: EXPERIMENTAL
Intervention: pRBC
Number of subjects: 763
Study 35393385 — intervention group
Group type: COMPARATOR
Intervention: TXA
Number of subjects: 763
Study 35393385 — intervention group
Group type: COMPARATOR
Intervention: Neither
Number of subjects: 763
Study 34388377 — intervention group
Group type: EXPERIMENTAL
Intervention: Bevacizumab plus erlotinib
Number of subjects: 311
Study 34388377 — intervention group
Group type: COMPARATOR
Intervention: Erlotinib only
Number of subjects: 311
Study 34388377 — intervention group
Group type: EXPERIMENTAL
Intervention: Bevacizumab plus erlotinib (in brain metastases subgroup)
Number of subjects: 311
Study 32277868 — intervention group
Group type: EXPERIMENTAL
Intervention: Switch from protease inhibitors to rilpivirine (RPV)
Number of subjects: 84
Study 32277868 — intervention group
Group type: COMPARATOR
Intervention: Continue ritonavir-boosted protease inhibitors (control group)
Number of subjects: 84
Study 36476171 — intervention group
Group type: EXPERIMENTAL
Intervention: Remimazolam 5 mg intravenously
Number of subjects: 150
Study 36476171 — intervention group
Group type: COMPARATOR
Intervention: Dexmedetomidine 0.6 µg/kg intravenously
Number of subjects: 150
Study 36476171 — intervention group
Group type: COMPARATOR
Intervention: Midazolam 0.025 mg/kg intravenously
Number of subjects: 150
Study 32618713 — intervention group
Group type: EXPERIMENTAL
Intervention: Antenatal administration of uterotonics
Number of subjects: 2608
Study 32618713 — intervention group
Group type: COMPARATOR
Intervention: Control group (live-born babies who died between day 8 and 28)
Number of subjects: 2608
Study 34074611 — intervention group
Group type: EXPERIMENTAL
Intervention: Symptom-titrated, algorithm-based longitudinal ECT (STABLE) plus pharmacotherapy (venlafaxine and lithium)
Number of subjects: 0
Study 34074611 — intervention group
Group type: COMPARATOR
Intervention: Pharmacotherapy-only
Number of subjects: 0
Study 34761243 — intervention group
Group type: EXPERIMENTAL
Intervention: Mindfulness-Based Health Program for Educators (MBHPEduca)
Number of subjects: 76
Study 34761243 — intervention group
Group type: COMPARATOR
Intervention: Neuroscience for Education program (Neuro‐Educa; active control)
Number of subjects: 76
Study 35840611 — intervention group
Group type: EXPERIMENTAL
Intervention: Probiotics, daily doses, duration of 28 days
Number of subjects: 0
Study 35840611 — intervention group
Group type: COMPARATOR
Intervention: Placebo, daily doses, duration of 28 days
Number of subjects: 0
Study 34840886 — intervention group
Group type: EXPERIMENTAL
Intervention: DBS on
Number of subjects: 18
Study 34840886 — intervention group
Group type: COMPARATOR
Intervention: DBS off
Number of subjects: 18
Study 36102961 — intervention group
Group type: EXPERIMENTAL
Intervention: Complex model
Number of subjects: 162
Study 36102961 — intervention group
Group type: COMPARATOR
Intervention: MRI reported model
Number of subjects: 162
Study 36102961 — intervention group
Group type: COMPARATOR
Intervention: Radscore model
Number of subjects: 162
Study 32043304 — intervention group
Group type: EXPERIMENTAL
Intervention: Enteral hydration (via NGT bolus, NGT continuous, both, or oral)
Number of subjects: 505
Study 32043304 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous fluids (IV)
Number of subjects: 505
Study 32043304 — intervention group
Group type: EXPERIMENTAL
Intervention: Both IV and enteral fluids
Number of subjects: 505
Study 32043304 — intervention group
Group type: EXPERIMENTAL
Intervention: NGT bolus
Number of subjects: 505
Study 32043304 — intervention group
Group type: EXPERIMENTAL
Intervention: NGT continuous
Number of subjects: 505
Study 32043304 — intervention group
Group type: EXPERIMENTAL
Intervention: Both NGT bolus and continuous
Number of subjects: 505
Study 32043304 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral hydration
Number of subjects: 505
Study 32043304 — intervention group
Group type: EXPERIMENTAL
Intervention: Mix of NGT and oral hydration
Number of subjects: 505
Study 33039508 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention group received educational materials (packed lunch planner, shopping list, information on sugar content, suggestions for healthier swaps) over a 4-week period.
Number of subjects: 17
Study 33039508 — intervention group
Group type: COMPARATOR
Intervention: Control group received no materials.
Number of subjects: 17
Study 33039508 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention group received educational materials.
Number of subjects: 17
Study 33268143 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral nutritional supplement (ONS) containing beta‐hydroxy‐beta‐methylbutyrate (HMB) with dietary counseling, two servings/day for 180 days.
Number of subjects: 811
Study 33268143 — intervention group
Group type: COMPARATOR
Intervention: Placebo supplement with dietary counseling, two servings/day for 180 days.
Number of subjects: 811
Study 33268143 — intervention group
Group type: EXPERIMENTAL
Intervention: ONS with dietary counseling
Number of subjects: 811
Study 33399351 — intervention group
Group type: EXPERIMENTAL
Intervention: Androgen receptor (AR) expression in UC/DEAC
Number of subjects: 16
Study 33399351 — intervention group
Group type: EXPERIMENTAL
Intervention: Androgen receptor (AR) expression in FIGO 3 endometrioid carcinoma
Number of subjects: 16
Study 33399351 — intervention group
Group type: EXPERIMENTAL
Intervention: Androgen receptor (AR) expression in serous carcinoma
Number of subjects: 16
Study 33399351 — intervention group
Group type: EXPERIMENTAL
Intervention: Androgen receptor (AR) expression in carcinosarcoma
Number of subjects: 16
Study 33399351 — intervention group
Group type: EXPERIMENTAL
Intervention: Androgen receptor (AR) expression in clear cell carcinoma
Number of subjects: 16
Study 33399351 — intervention group
Group type: EXPERIMENTAL
Intervention: Association of AR expression with hormone receptors in UC/DEAC
Number of subjects: 16
Study 33399351 — intervention group
Group type: EXPERIMENTAL
Intervention: HER2 expression in UC/DEAC
Number of subjects: 16
Study 33399351 — intervention group
Group type: EXPERIMENTAL
Intervention: HER2 expression in other high-grade carcinomas
Number of subjects: 16
Study 33399351 — intervention group
Group type: EXPERIMENTAL
Intervention: Association of loss of AR with clinicopathologic parameters in UC/DEAC
Number of subjects: 16
Study 33399351 — intervention group
Group type: EXPERIMENTAL
Intervention: Potential role of androgen inhibitors in management of UC/DEAC
Number of subjects: 16
Study 33396496 — intervention group
Group type: EXPERIMENTAL
Intervention: Creative Music Therapy (CMT)
Number of subjects: 16
Study 33396496 — intervention group
Group type: COMPARATOR
Intervention: Control Group (CG)
Number of subjects: 16
Study 35209785 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive Remediation (CR), n=64
Number of subjects: 148
Study 35209785 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive Behavior Therapy (CBT), n=84
Number of subjects: 148
Study 35209785 — intervention group
Group type: EXPERIMENTAL
Intervention: Vocational Rehabilitation (VR)
Number of subjects: 148
Study 34448866 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous cardiac rhythm monitoring for 30 days after randomization
Number of subjects: 336
Study 34448866 — intervention group
Group type: COMPARATOR
Intervention: Usual care (no mandated monitoring)
Number of subjects: 336
Study 36475816 — intervention group
Group type: EXPERIMENTAL
Intervention: Lipiodol‐bleomycin emulsion and NBCA‐Lipiodol emulsion
Number of subjects: 72
Study 36475816 — intervention group
Group type: COMPARATOR
Intervention: PVA
Number of subjects: 72
Study 33883199 — intervention group
Group type: EXPERIMENTAL
Intervention: Personalised information about spirometry results (Intervention Group - IG)
Number of subjects: 571
Study 33883199 — intervention group
Group type: COMPARATOR
Intervention: Brief smoking cessation advice (Control Group - CG)
Number of subjects: 571
Study 33883199 — intervention group
Group type: EXPERIMENTAL
Intervention: Cumulative abstinence curve (Intervention Group - IG)
Number of subjects: 571
Study 32564674 — intervention group
Group type: EXPERIMENTAL
Intervention: Knowledge of result (KR) during vertical jump testing
Number of subjects: 16
Study 32564674 — intervention group
Group type: COMPARATOR
Intervention: No knowledge of result (without KR) during vertical jump testing
Number of subjects: 16
Study 34192421 — intervention group
Group type: EXPERIMENTAL
Intervention: Visual abstracts
Number of subjects: 307
Study 34192421 — intervention group
Group type: COMPARATOR
Intervention: Control group (no visual abstracts)
Number of subjects: 307
Study 35227407 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive Rehearsal
Number of subjects: 88
Study 35227407 — intervention group
Group type: EXPERIMENTAL
Intervention: Memory Substitution
Number of subjects: 88
Study 32232364 — intervention group
Group type: EXPERIMENTAL
Intervention: Public hospitals
Number of subjects: 873
Study 32232364 — intervention group
Group type: EXPERIMENTAL
Intervention: Health centers
Number of subjects: 873
Study 32232364 — intervention group
Group type: EXPERIMENTAL
Intervention: Private facilities
Number of subjects: 873
Study 32232364 — intervention group
Group type: EXPERIMENTAL
Intervention: Urban facilities
Number of subjects: 873
Study 32232364 — intervention group
Group type: EXPERIMENTAL
Intervention: Rural facilities
Number of subjects: 873
Study 32232364 — intervention group
Group type: COMPARATOR
Intervention: Health centers vs. hospitals
Number of subjects: 873
Study 32232364 — intervention group
Group type: COMPARATOR
Intervention: Private facilities vs. hospitals
Number of subjects: 873
Study 32232364 — intervention group
Group type: EXPERIMENTAL
Intervention: Regions
Number of subjects: 873
Study 33131909 — intervention group
Group type: EXPERIMENTAL
Intervention: Duodenal-jejunal bypass liner (DJBL) for 12 months
Number of subjects: 70
Study 33131909 — intervention group
Group type: COMPARATOR
Intervention: Best medical therapy, diet and exercise
Number of subjects: 70
Study 32794487 — intervention group
Group type: EXPERIMENTAL
Intervention: Proanthocyanidin (6.5%)
Number of subjects: 80
Study 32794487 — intervention group
Group type: EXPERIMENTAL
Intervention: Genipin (6.5%)
Number of subjects: 80
Study 32794487 — intervention group
Group type: EXPERIMENTAL
Intervention: Glutaraldehyde (6.5%)
Number of subjects: 80
Study 32794487 — intervention group
Group type: COMPARATOR
Intervention: Control (no primer application)
Number of subjects: 80
Study 35907471 — intervention group
Group type: EXPERIMENTAL
Intervention: Preference music (PM)
Number of subjects: 11
Study 35907471 — intervention group
Group type: EXPERIMENTAL
Intervention: Non-preference music (nPM)
Number of subjects: 11
Study 35907471 — intervention group
Group type: COMPARATOR
Intervention: Without music (WM)
Number of subjects: 11
Study 33559245 — intervention group
Group type: EXPERIMENTAL
Intervention: Magnesium (200 mg) combined with 2 ml bupivacaine and 1 ml (40 mg) methylprednisolone
Number of subjects: 50
Study 33559245 — intervention group
Group type: COMPARATOR
Intervention: Control group (2 ml bupivacaine, 1 ml (40 mg) methylprednisolone and 1 ml saline (0.9%))
Number of subjects: 50
Study 32162821 — intervention group
Group type: EXPERIMENTAL
Intervention: Stereotactic body radiotherapy (SBRT) of 16 Gy in 1 fraction
Number of subjects: 10
Study 32162821 — intervention group
Group type: COMPARATOR
Intervention: Decompression surgery followed by fractionated radiotherapy of 30 Gy in 10 fractions
Number of subjects: 10
Study 34037911 — intervention group
Group type: EXPERIMENTAL
Intervention: Hydroxychloroquine (200mg BID)
Number of subjects: 51
Study 34037911 — intervention group
Group type: COMPARATOR
Intervention: Observation
Number of subjects: 51
Study 33369824 — intervention group
Group type: EXPERIMENTAL
Intervention: Analgesic treatment and MET (Medical Expulsive Therapy)
Number of subjects: 14
Study 33369824 — intervention group
Group type: EXPERIMENTAL
Intervention: Surgical intervention
Number of subjects: 14
Study 34297066 — intervention group
Group type: EXPERIMENTAL
Intervention: Adipose tissue-derived stromal vascular fraction (AD-SVF) injection
Number of subjects: 40
Study 34297066 — intervention group
Group type: COMPARATOR
Intervention: Placebo (lactated Ringer's solution)
Number of subjects: 40
Study 34682824 — intervention group
Group type: EXPERIMENTAL
Intervention: Hyaluronic acid/trehalose ophthalmic solution (Thealoz® Duo) three times/day in the preoperative week and for 5 postoperative weeks (Group A)
Number of subjects: 120
Study 34682824 — intervention group
Group type: EXPERIMENTAL
Intervention: Hyaluronic acid/trehalose ophthalmic solution (Thealoz® Duo) for only 5 postoperative weeks (Group B)
Number of subjects: 120
Study 34682824 — intervention group
Group type: COMPARATOR
Intervention: No artificial tears (Group C)
Number of subjects: 120
Study 36192800 — intervention group
Group type: EXPERIMENTAL
Intervention: Nordic walking intervention (two sessions per week for twelve weeks)
Number of subjects: 144
Study 36192800 — intervention group
Group type: EXPERIMENTAL
Intervention: Nordic walking plus socio-ecological approach (two sessions per week for twelve weeks)
Number of subjects: 144
Study 36192800 — intervention group
Group type: COMPARATOR
Intervention: Usual healthcare professionals’ walking advice on physical activity (control group)
Number of subjects: 144
Study 36192800 — intervention group
Group type: EXPERIMENTAL
Intervention: Not available
Number of subjects: 144
Study 34006266 — intervention group
Group type: EXPERIMENTAL
Intervention: Adaptation of WHO PEN/HEARTS clinical algorithms, two-day training of doctors and nurses, supportive supervision visits, clinical decision support tools, quality improvement support.
Number of subjects: 1085
Study 34006266 — intervention group
Group type: COMPARATOR
Intervention: Usual care (control group).
Number of subjects: 1085
Study 34006266 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention clinics (relative to control).
Number of subjects: 1085
Study 34006266 — intervention group
Group type: COMPARATOR
Intervention: Control clinics (relative to intervention).
Number of subjects: 1085
Study 32205595 — intervention group
Group type: EXPERIMENTAL
Intervention: Early and progressive mobility program with five levels of activity
Number of subjects: 99
Study 32205595 — intervention group
Group type: COMPARATOR
Intervention: Conventional treatment without a preestablished routine
Number of subjects: 99
Study 32205595 — intervention group
Group type: EXPERIMENTAL
Intervention: Early and progressive mobility program
Number of subjects: 99
Study 36065580 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive Remediation Therapy (CRT) added to IPS
Number of subjects: 97
Study 36065580 — intervention group
Group type: COMPARATOR
Intervention: IPS alone
Number of subjects: 97
Study 33960404 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexmedetomidine
Number of subjects: 63
Study 33960404 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 63
Study 32827344 — intervention group
Group type: EXPERIMENTAL
Intervention: Automated oxygen administration using the FreeO2 device
Number of subjects: 60
Study 32827344 — intervention group
Group type: COMPARATOR
Intervention: Conventional manual oxygen administration
Number of subjects: 60
Study 32047601 — intervention group
Group type: EXPERIMENTAL
Intervention: Multiple visit endodontic treatment with triple antibiotic paste interappointment dressing
Number of subjects: 44
Study 32047601 — intervention group
Group type: COMPARATOR
Intervention: Single visit endodontic treatment without interappointment dressing
Number of subjects: 44
Study 34032760 — intervention group
Group type: EXPERIMENTAL
Intervention: Early Mobilization (EM) protocol
Number of subjects: 60
Study 34032760 — intervention group
Group type: COMPARATOR
Intervention: Standard Early Rehabilitation (SER) protocol
Number of subjects: 60
Study 33152035 — intervention group
Group type: EXPERIMENTAL
Intervention: Electrical stimulation of the triceps surae muscles (NMES)
Number of subjects: 8
Study 35069801 — intervention group
Group type: COMPARATOR
Intervention: Large-caliber endoscope (LCE)
Number of subjects: 45
Study 35069801 — intervention group
Group type: EXPERIMENTAL
Intervention: Small-caliber endoscope (SCE)
Number of subjects: 45
Study 33395182 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-volume plyometric training (40-60 ground contacts per session, twice weekly) in HV-1 group
Number of subjects: 32
Study 33395182 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-volume plyometric training (40-60 ground contacts per session, twice weekly) in VH-2 group
Number of subjects: 32
Study 33395182 — intervention group
Group type: COMPARATOR
Intervention: Control group (no plyometric training)
Number of subjects: 32
Study 33395182 — intervention group
Group type: EXPERIMENTAL
Intervention: Vertical plyometrics
Number of subjects: 32
Study 35061525 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultralow-risk patients (n = 1,000)
Number of subjects: 1000
Study 35061525 — intervention group
Group type: COMPARATOR
Intervention: Low-risk patients (n = 3,295)
Number of subjects: 1000
Study 34852839 — intervention group
Group type: EXPERIMENTAL
Intervention: Proactive telephone peer support intervention
Number of subjects: 693
Study 34852839 — intervention group
Group type: EXPERIMENTAL
Intervention: First call support
Number of subjects: 693
Study 34852839 — intervention group
Group type: EXPERIMENTAL
Intervention: Support at ≥12 weeks postpartum
Number of subjects: 693
Study 34852839 — intervention group
Group type: EXPERIMENTAL
Intervention: Referrals during calls
Number of subjects: 693
Study 35154343 — intervention group
Group type: EXPERIMENTAL
Intervention: Golden plaster
Number of subjects: 320
Study 35154343 — intervention group
Group type: COMPARATOR
Intervention: Placebo plaster
Number of subjects: 320
Study 35154343 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 320
Study 33239100 — intervention group
Group type: EXPERIMENTAL
Intervention: Real-time continuous glucose monitoring (CGM) with the Dexcom G6
Number of subjects: 72
Study 33239100 — intervention group
Group type: COMPARATOR
Intervention: Finger-prick glucose monitoring (blinded CGM)
Number of subjects: 72
Study 33239100 — intervention group
Group type: EXPERIMENTAL
Intervention: Real-time CGM
Number of subjects: 72
Study 33239100 — intervention group
Group type: COMPARATOR
Intervention: Finger-prick glucose monitoring
Number of subjects: 72
Study 33587781 — intervention group
Group type: EXPERIMENTAL
Intervention: Mouth Care Matters (MCM) program offered to all CNAs in NF-A
Number of subjects: 24
Study 33587781 — intervention group
Group type: COMPARATOR
Intervention: Mouth Care Matters (MCM) program offered to 3 CNAs in NF-B
Number of subjects: 24
Study 33587781 — intervention group
Group type: COMPARATOR
Intervention: Control group (no CNAs offered MCM program in NF-C)
Number of subjects: 24
Study 36271441 — intervention group
Group type: EXPERIMENTAL
Intervention: Remote consent
Number of subjects: 156
Study 36271441 — intervention group
Group type: EXPERIMENTAL
Intervention: Remote site initiation visits (SIVs)
Number of subjects: 156
Study 36271441 — intervention group
Group type: EXPERIMENTAL
Intervention: Remote data monitoring
Number of subjects: 156
Study 32421171 — intervention group
Group type: EXPERIMENTAL
Intervention: Relaxation Response Resiliency Program for NF (3RP‐NF) via live videoconferencing
Number of subjects: 63
Study 32421171 — intervention group
Group type: COMPARATOR
Intervention: Attention placebo control
Number of subjects: 63
Study 36184472 — intervention group
Group type: EXPERIMENTAL
Intervention: Low tidal volume (LTV), pressure controlled ventilation (PCV), respiratory rate (RR) 20‐to‐30/min, peak inspiratory pressure adjusted to keep tidal volume (Vt) 2 mL/kg
Number of subjects: 120
Study 36184472 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous positive airway pressure (CPAP) of 5 cmH2O
Number of subjects: 120
Study 36184472 — intervention group
Group type: COMPARATOR
Intervention: No mechanical ventilation (NOV)
Number of subjects: 120
Study 32949078 — intervention group
Group type: EXPERIMENTAL
Intervention: 'Brown envelope' intervention for digital professionalism awareness training
Number of subjects: 11
Study 35218867 — intervention group
Group type: EXPERIMENTAL
Intervention: Hydrus Microstent (HMS)
Number of subjects: 556
Study 35218867 — intervention group
Group type: COMPARATOR
Intervention: Cataract Surgery (CS) only
Number of subjects: 556
Study 32078145 — intervention group
Group type: EXPERIMENTAL
Intervention: HS016
Number of subjects: 648
Study 32078145 — intervention group
Group type: COMPARATOR
Intervention: adalimumab
Number of subjects: 648
Study 36344005 — intervention group
Group type: EXPERIMENTAL
Intervention: Liberal oxygen strategy (12-15 L O2/min or FiO2=0.6-1.0)
Number of subjects: 1420
Study 36344005 — intervention group
Group type: COMPARATOR
Intervention: Restrictive oxygen strategy (>21% oxygen to ensure SpO2 of 94%)
Number of subjects: 1420
Study 34226449 — intervention group
Group type: EXPERIMENTAL
Intervention: Clotrimazole 1% solution
Number of subjects: 102
Study 34226449 — intervention group
Group type: COMPARATOR
Intervention: Econazole Nitrate 1% + Triamcinolone Acetonide 0.1% cream
Number of subjects: 102
Study 32147926 — intervention group
Group type: EXPERIMENTAL
Intervention: Intention to treat (ITT) analysis
Number of subjects: 0
Study 32147926 — intervention group
Group type: EXPERIMENTAL
Intervention: Per protocol (PP) analysis
Number of subjects: 0
Study 32956782 — intervention group
Group type: EXPERIMENTAL
Intervention: HCQ/AZT combination
Number of subjects: 112
Study 32956782 — intervention group
Group type: EXPERIMENTAL
Intervention: HCQ only
Number of subjects: 112
Study 32956782 — intervention group
Group type: COMPARATOR
Intervention: No treatment
Number of subjects: 112
Study 32956782 — intervention group
Group type: EXPERIMENTAL
Intervention: Older age
Number of subjects: 112
Study 32956782 — intervention group
Group type: EXPERIMENTAL
Intervention: All groups
Number of subjects: 112
Study 33896809 — intervention group
Group type: EXPERIMENTAL
Intervention: Sahrmann corrective exercises
Number of subjects: 30
Study 33896809 — intervention group
Group type: COMPARATOR
Intervention: NASM corrective exercises
Number of subjects: 30
Study 32169068 — intervention group
Group type: EXPERIMENTAL
Intervention: Small-incision cataract surgery in diabetic patients
Number of subjects: 59
Study 32169068 — intervention group
Group type: COMPARATOR
Intervention: Small-incision cataract surgery in control patients
Number of subjects: 59
Study 32572664 — intervention group
Group type: EXPERIMENTAL
Intervention: HIPEC plus adjuvant chemotherapy
Number of subjects: 352
Study 32572664 — intervention group
Group type: COMPARATOR
Intervention: Conventional chemotherapy
Number of subjects: 352
Study 32464799 — intervention group
Group type: EXPERIMENTAL
Intervention: Extracorporeal photopheresis plus standard immunosuppressive therapy (ECP)
Number of subjects: 24
Study 32464799 — intervention group
Group type: COMPARATOR
Intervention: Standard immunosuppressive therapy (CTR)
Number of subjects: 24
Study 36096487 — intervention group
Group type: EXPERIMENTAL
Intervention: High intra-abdominal pressure (IAP) during HIPEC (>=18 mmHg)
Number of subjects: 40